Diagnosing COVID-19-associated pulmonary aspergillosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gangneux, 2020, Invasive fungal diseases during COVID-19: we should be prepared, J Mycol Med, 10.1016/j.mycmed.2020.100971
Zhang, 2020, Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China, J Clin Virol, 127, 10.1016/j.jcv.2020.104364
Wang, 2003, Fatal aspergillosis in a patient with SARS who was treated with corticosteroids, N Engl J Med, 349, 507, 10.1056/NEJM200307313490519
Alanio A, Dellière S, Fodil S, Bretagne S, Bruno Mégarbane B. High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients. SSRN 2020; published online April 15. 3575581 (abstr).
Schauwvlieghe, 2018, Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study, Lancet Respir Med, 6, 782, 10.1016/S2213-2600(18)30274-1
Meersseman, 2008, Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients, Am J Respir Crit Care Med, 177, 27, 10.1164/rccm.200704-606OC
Henriet, 2013, Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease, J Infect Dis, 207, 1932, 10.1093/infdis/jit103
Dewi IMW, Cunha C, Vanderbeke L, et al. Oseltamivir affects host defense against invasive pulmonary aspergillosis. European Conference on Clinical Microbiology and Infectious Diseases; Madrid; April 21–24, 2018. Abstract O1115.
Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, 10.1172/JCI137244